Camera Capsule Endoscopy in the Routine Diagnostic Pathway for Colorectal Diseases
Odense University Hospital
800 participants
Nov 27, 2024
INTERVENTIONAL
Conditions
Summary
The Department of Surgery at Odense University Hospital (OUH) carries out approximately 10,000 colonoscopies each year, and this number is continuously increasing. Since 2014, the screening for colorectal cancer (CRC) has resulted in a significant increase in the colonoscopy workload. Conventional colonoscopy (CC) is a hospital-based procedure that can require sedation or analgesics and is often considered uncomfortable, intimidating, or even painful. The diagnostic yield of CC can be as low as 3-5% in some patient groups, which means that an endoscopist may need to perform 20 to 30 colonoscopies to identify one case requiring treatment. Physical or cultural barriers can also deter patients from attending appointments, leading to missed cancers or precancerous lesions. To address these challenges, an alternative pathway is needed to reduce the colonoscopy burden on the healthcare system while ensuring fewer findings are missed. One solution is to use Colon Capsule Endoscopy (CCE) as a triage tool. This procedure can be performed in outpatient healthcare centers and requires less equipment than an CC. However, CCE offers no therapeutic capability, and individuals with clinically significant findings will still require an CC. A low reinvestigation rate (\<25%-30%) is desirable for patient preference and the economy. Therefore, DanCap will introduce a new pathway that relies on CCE for routine colorectal examinations of symptomatic patients who are expected to have a low rate of positive findings and, consequently, a low reinvestigation rate, and asses the cost of this new pathway.
Eligibility
Inclusion Criteria3
- Older than 18 years
- Symptomatic patient referred for colonoscopy assessment
- Able to provide oral and written informed consent
Exclusion Criteria12
- Require hospital admission for inpatient colonoscopy
- Previous OC with poor bowel preparation within the last 5 years
- Patient is unable to provide oral and written informed consent
- History of stenosis of the digestive tract
- Previous major surgery of the digestive tract with consequence of an internal derivation or a stoma\*
- Patient has a pacemaker/defibrillator
- Patient is pregnant or breastfeeding
- Known allergies to the bowel preparation regimen
- Have severe kidney disease
- Known chronic constipation
- Imaging examination suggestive for a colorectal tumour
- Anamnestic suspicion of microscopic colitis, where biopsy is needed \*including Whipple
Interventions
Twice a week, patients will attend the in-hospital clinic in groups of four persons. They will bring their completed FIT sample, questionnaire, and the signed consent form. A project nurse will administer the capsules in the morning, and the patients can leave after. When the capsule investigation is completed, patients must return their belt and receiver to the Department of Surgery, OUH. After a few days, the patient will receive an electronic letter with the results and information regarding upcoming steps. Those with positive findings or an incomplete investigation will be given a new appointment according to the current clinical routine. A second questionnaire will be sent to the patient 2 weeks after the completed procedure.
Patients will start bowel cleansing according to the instructions. They will bring their completed questionnaire and the signed consent form to the scheduled colonoscopy. They will continue to follow the routine clinical setup for outpatient colonoscopy and will only receive, by digital post, after 2 weeks from the procedure, an extra second questionnaire.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06475560